Antibody:	Anti-Foxd3
Assay notes:	Then antibody reference described two Foxd3 antibodies MGI:7785103 and MGI:7785096; the one used in this assay was not specified.

Structure	Cell Type	Level	Pattern	Image	Note
TS13: neural crest	neural crest cell	Present	Regionally restricted	1C	Expression was detected in premigratory and migratory cranial neural crest cells.
TS13: migrating neural crest	migratory neural crest cell	Present	Regionally restricted	1C	Expression was detected in migratory cranial neural crest cells.

Structure	Level	Pattern	Image	Note
TS20: dorsal root ganglion	Present		1F	At 12.5 dpc Foxd3 and Sox2 are co-expressed in the dorsal root ganglion.

Structure	Level	Pattern	Image	Note
TS21: vibrissa dermal component	Present	Regionally restricted	2A , 2B , 2D	Expression was detected on the periphery of the dermal condensates. Co-expression with Sox2 was observed.

Structure	Level	Pattern	Image	Note
TS25: vibrissa dermal papilla	Present		2F , 2E , 2H	Expression was detected in the neural crest lineage in the dermal papilla. Co-expression with Sox2 was observed.
TS25: head mesenchyme	Present	Regionally restricted	2H , 2F , 2E	Expression was observed in cranial mesenchyme that did not co-express with Sox2.

Structure	Level	Pattern	Image	Note
TS25: vibrissa follicle	Present	Regionally restricted	5B , 5A , 5D	Expression was detected in the neural crest lineage, where it overlapped with Sox2.

Structure	Level	Pattern	Image	Note
TS25: vibrissa follicle	Present	Regionally restricted	5E , 5H , 5F	Expression was detected in the neural crest lineage, but co-expression with Sox2 was lost in the mutant.